Cargando…

Trough Melatonin Levels Differ between Early and Late Phases of Alzheimer Disease

OBJECTIVE: Melatonin has been considered to have an essential role in the pathophysiology of Alzheimer’s disease (AD) for its regulatory function on circadian rhythm and interaction with glutamate for the modulation of learning and memory. Previous studies revealed that melatonin levels decreased in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Chieh-Hsin, Chiu, Chih-Chiang, Lane, Hsien-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851471/ https://www.ncbi.nlm.nih.gov/pubmed/33508797 http://dx.doi.org/10.9758/cpn.2021.19.1.135

Ejemplares similares

In Reply: Trough Melatonin Levels Have No Physiological or Clinical Relevance
por: Lin, Chieh-Hsin, et al.
Publicado: (2021)

pLG72 levels increase in early phase of Alzheimer’s disease but decrease in late phase
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Trough Melatonin Levels Have No Physiological or Clinical Relevance
por: Kennaway, David J.
Publicado: (2021)

Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging
por: Lin, Chieh-Hsin, et al.
Publicado: (2017)

Molecular Basis of Late-Life Depression
por: Kuo, Chien-Yi, et al.
Publicado: (2021)

Brain Stimulation in Alzheimer's Disease
por: Chang, Chun-Hung, et al.
Publicado: (2018)

Deep Learning with Neuroimaging and Genomics in Alzheimer’s Disease
por: Lin, Eugene, et al.
Publicado: (2021)

Novel Biomarkers of Alzheimer’s Disease: Based Upon N-methyl- D-aspartate Receptor Hypoactivation and Oxidative Stress
por: Chiang, Ting-I, et al.
Publicado: (2021)

d-glutamate and Gut Microbiota in Alzheimer’s Disease
por: Chang, Chun-Hung, et al.
Publicado: (2020)

Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer’s Disease
por: Chang, Chun-Hung, et al.
Publicado: (2021)

Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review
por: Yu, Tien-Wei, et al.
Publicado: (2021)

Vancomycin trough level and loading dose
por: Tuon, Felipe Francisco, et al.
Publicado: (2018)

Diagnosing Alzheimer’s Disease Specifically and Sensitively With pLG72 and Cystine/Glutamate Antiporter SLC7A11 AS Blood Biomarkers
por: Lane, Hsien-Yuan, et al.
Publicado: (2022)

d-Amino Acids and pLG72 in Alzheimer’s Disease and Schizophrenia
por: Cheng, Yu-Jung, et al.
Publicado: (2021)

Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer’s Disease
por: Cheng, Yu-Jung, et al.
Publicado: (2021)

Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
por: Hsu, Wen-Yu, et al.
Publicado: (2018)

Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Tacrolimus trough levels in kidney transplant recipients
por: Hwang, Young Hui, et al.
Publicado: (2021)

Of waves and troughs
por: Noll-Hussong, Michael
Publicado: (2014)

NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer’s Disease
por: Huang, Yu-Jhen, et al.
Publicado: (2012)

Plasma Glutathione Levels Decreased with Cognitive Decline among People with Mild Cognitive Impairment (MCI): A Two-Year Prospective Study
por: Lin, Chieh-Hsin, et al.
Publicado: (2021)

Long-Term Tacrolimus Blood Trough Level and Patient Survival in Adult Liver Transplantation
por: Hsiao, Chih-Yang, et al.
Publicado: (2021)

Blood D-Amino Acid Oxidase Levels Increased With Cognitive Decline Among People With Mild Cognitive Impairment: A Two-Year Prospective Study
por: Lin, Chieh-Hsin, et al.
Publicado: (2022)

Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease
por: Manchia, Mirko, et al.
Publicado: (2019)

Early and late-onset Alzheimer's disease: What are the differences?
por: Awada, Adnan A.
Publicado: (2015)

Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose‐finding, randomized, double‐blind, placebo‐controlled trial for Alzheimer's disease
por: Lane, Hsien‐Yuan, et al.
Publicado: (2022)

Differences between Early and Late-Onset Alzheimer’s Disease in Neuropsychological Tests
por: Sá, Francisca, et al.
Publicado: (2012)

Optimal trough levels in haemophilia B: Raising expectations
por: Walsh, Christopher, et al.
Publicado: (2020)

Assessing the association between cefepime percentage free trough level and neurotoxicity
por: Zia, Aleena, et al.
Publicado: (2022)

Effects of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, on Perceived Stress and Cognitive Function Among Patients With Late-Life Depression: A Randomized, Double-Blind, Sertraline- and Placebo-Controlled Trial
por: Lin, Chieh-Hsin, et al.
Publicado: (2022)

D2 dopamine receptor gene (DRD2) Taq1A (rs1800497) affects bone density
por: Chiang, Ting-I., et al.
Publicado: (2020)

Street Troughs and Glanders
Publicado: (1892)

Danger in the Water Trough
Publicado: (1885)

Serum Daytime Melatonin Levels Reflect Cerebrospinal Fluid Melatonin Levels in Alzheimer’s Disease but Are Not Correlated with Cognitive Decline
por: Nous, Amber, et al.
Publicado: (2021)

Effects of Antipsychotics on Bone Mineral Density in Patients with Schizophrenia: Gender Differences
por: Chen, Chien-Yu, et al.
Publicado: (2016)

Melatonin in Alzheimer’s Disease
por: Lin, Li, et al.
Publicado: (2013)

Changes in imatinib plasma trough level during long-term treatment in patients with intermediate- or high-risk gastrointestinal stromal tumors: Relationship between covariates and imatinib plasma trough level
por: Wu, Xingye, et al.
Publicado: (2023)

Tear trough deformity: different types of anatomy and treatment options
por: Jiang, Jindou, et al.
Publicado: (2016)

Melatonin levels in the Alzheimer’s disease continuum: a systematic review
por: Nous, Amber, et al.
Publicado: (2021)

Early- and Late-Luteal-Phase Estrogen and Progesterone Levels of Women with Premenstrual Dysphoric Disorder
por: Yen, Ju-Yu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_btat0ekldc0hjrh9brka5qnukm